Variability in PET quantitation within a multicenter consortium. - Wikidata - awgldk - TriplyDB

Variability in PET quantitation within a multicenter consortium.

Variability in PET quantitation within a multicenter consortium.

http://www.wikidata.org/entity/Q34000970

about

A review on segmentation of positron emission tomography images Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures.Performance Observations of Scanner Qualification of NCI-Designated Cancer Centers: Results From the Centers of Quantitative Imaging Excellence (CQIE) Program "RADIOTRANSCRIPTOMICS": A synergy of imaging and transcriptomics in clinical assessment Multicenter trials using ¹⁸F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: effects of differential measurement error and bias on power calculations for unselected and enrichment designs.Role of PET quantitation in the monitoring of cancer response to treatment: Review of approaches and human clinical trials.Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT.18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortium Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium.Design considerations for using PET as a response measure in single site and multicenter clinical trials.Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapy Noise considerations for PET quantification using maximum and peak standardized uptake value.Early experiences in establishing a regional quantitative imaging network for PET/CT clinical trials.Variability of Image Features Computed from Conventional and Respiratory-Gated PET/CT Images of Lung Cancer.Quantitative Imaging in Cancer Clinical Trials Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium.Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings Receiver operating characteristic (ROC) curve for classification of (18)F-NaF uptake on PET/CT.Scanning linear estimation: improvements over region of interest (ROI) methods.The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose posit Joint segmentation of anatomical and functional images: applications in quantification of lesions from PET, PET-CT, MRI-PET, and MRI-PET-CT images Tumor quantification in clinical positron emission tomography.Biases in Multicenter Longitudinal PET Standardized Uptake Value Measurements.A Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment.Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials.PET/MRI: Where might it replace PET/CT?Microfocus x-ray imaging of traceable pointlike 22 Na sources for quality control.Technical Note: Transconvolution based equalization of positron energy effects for the use of 68 Ge/68 Ga phantoms in determining 18 F PET recovery.Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials.Longitudinal monitoring of reconstructed activity concentration on a clinical time-of-flight PET/CT scanner.Technical Note: Rod phantom analysis for comparison of PET detector sampling and reconstruction methods.Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor.Guidelines for quality control of PET/CT scans in a multicenter clinical study Repeatability of SUV measurements in serial PET.EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems.Correlation of 18F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.Multicenter survey of PET/CT protocol parameters that affect standardized uptake values.Validation of novel calibration scheme with traceable point-like (22)Na sources on six types of PET scanners.Multi institutional quantitative phantom study of yttrium-90 PET in PET/MRI: the MR-QUEST study.Robustness of quantitative hypoxia PET image analysis for predicting local tumor control.

P2860

Q26825470-0E16F137-E24A-4084-A57E-C3A0D03A7D1D Q30645097-62FF5F65-8C55-4AE4-A235-310F516F9E6B Q33556331-32371156-A4C7-4423-A47E-D3310046ED63 Q33704494-48271D05-5500-4D31-86DD-BDFF034D2B3F Q33921056-A6B5CE9E-F990-4385-90A0-5DF87F8AA927 Q34175770-B92A25E0-F218-4D27-B28B-F42E02EF62FD Q34336023-F4098488-3956-460F-85CF-B87023E316ED Q34598876-BCA49C5A-8356-42D3-B541-2F88B46AF24F Q34610598-B2836538-5511-4784-AE13-20ECA621C952 Q35653277-FCEBC018-E5D5-4F5C-9DAF-310A15E3CCA6 Q35789209-D8827596-9314-4504-9AD8-927B2F931B02 Q36158583-FD8E4ABF-25DE-4ECC-95D9-87A48CD10421 Q36303559-9808BFFA-D6C5-4C62-B36D-F2EB66CE6B6E Q36427534-04DA86E3-B8BE-47D9-B037-692F05038E79 Q36477059-8C4D28C0-D904-4557-AB3D-E5E42149FA9B Q36479298-84BDBD87-1651-4D86-B42B-FDC16C276426 Q36626050-CC9045D4-D8A5-4228-9790-4B1A4F697A7B Q36628451-86E8FA7C-BE74-459E-B53D-925707D6C144 Q36731371-6A995B3B-FA93-42A1-80B0-E50844A8AB21 Q37192658-A17CF073-295B-4D85-941F-6B235A2BFE98 Q37228057-093F44CB-09F6-48B2-BD0D-37AD33AED55A Q37342658-A5CF975D-A192-4764-AF50-7D0DF30ED02A Q37721524-77B706C9-87C3-4907-BB9D-4C3C989BFC87 Q37721526-6BB0C10B-3E0E-42A2-8307-4FEC9E3D0B31 Q38000044-041FA3B0-A4C1-4AAB-B921-34E7B4404C75 Q38735917-FB9546DD-DF78-4822-8EEF-6625ECCEEF9D Q38779258-F614D32A-981A-4270-A15C-2681E2FC0E94 Q38791981-337C84FA-E48C-446C-8EF9-141FD9DBC630 Q38932290-2A61D87D-C8F6-46A3-81F8-39117AD6D7EF Q39127862-88A1F97B-A00F-437E-9410-13F34F46D682 Q39223318-F8FEE52E-3E3E-4268-BCCE-D93454B1B0D7 Q41303066-39FC648A-E87E-47E5-B32A-B7235F0094EC Q41683890-B147C2EC-91D4-4144-AADE-8AC66616B028 Q43643017-75C386FD-4814-439B-9BF2-1FA7888BA829 Q47388017-8E64807E-D26A-48EE-B77E-79737BCA8694 Q48237727-540C31DC-438C-42EF-B556-E39D247989CE Q49694520-FE52FB52-6AC2-4073-84FB-F1857AD70C19 Q51265116-DDCB4753-D92A-4856-A2F4-FB0817AD26E0 Q52608240-804D3976-052F-4449-B94B-BCA964CB5533 Q52990174-BFD3D3E9-B12B-4211-AFBE-D58A59DF1C59

P2860

Variability in PET quantitation within a multicenter consortium.

http://www.wikidata.org/entity/Q34000970

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Variability in PET quantitation within a multicenter consortium.

@ast

Variability in PET quantitation within a multicenter consortium.

@en

Variability in PET quantitation within a multicenter consortium.

@nl

type

label

Variability in PET quantitation within a multicenter consortium.

@ast

Variability in PET quantitation within a multicenter consortium.

@en

Variability in PET quantitation within a multicenter consortium.

@nl

prefLabel

Variability in PET quantitation within a multicenter consortium.

@ast

Variability in PET quantitation within a multicenter consortium.

@en

Variability in PET quantitation within a multicenter consortium.

@nl

P1433

Q34000970-30866B7D-D715-48D6-97C4-10EB2E7FE8E6

P1476

Q34000970-5CAC79FC-88A0-42A6-84A3-E88550EA457C

P2093

Q34000970-628DD165-C385-4FFD-937C-6F7A5B32EAD6

Q34000970-85F88227-D8CE-42B3-BD11-99FF3CEC3733

Q34000970-A08061C2-53CB-4C82-BA58-D6DD54BF9867

Q34000970-AFE25D79-FEEE-4DD2-AF26-AD00DF9CC811

Q34000970-C0E8D5DF-AA80-4732-BE52-4A04B6FA2FCD

Q34000970-FA7AC0F3-ED80-45A8-9B82-4EBCAC24C967

P2860

Q34000970-05CB7891-20A4-4EF4-8444-1EA11AEDD1A3

Q34000970-09993905-E38A-4E25-B2B8-D3538F0E9EAF

Q34000970-10633634-7DB5-426D-9AE9-29EA41205076

Q34000970-121A9DDB-4BD5-49C0-859E-09FAF868219F

Q34000970-1FC7E75C-E50C-4540-8A60-3150E8CBC555

Q34000970-2DB66FFC-CAB8-4F67-87AE-3875D4843AD4

Q34000970-332ED9C3-B286-4D4D-82D7-3E601FD91B37

Q34000970-3628D020-30CE-4F4E-841E-85ADF6F66E39

Q34000970-3876ED44-7B2E-44DE-8951-676B6A1D2696

Q34000970-4F4BD934-097C-48BD-B3A2-4F706317A013

P304

Q34000970-02325AAF-BB00-4942-A9DC-45EEFF722934

P31

Q34000970-82FA3639-5BBB-4857-82C9-4789529694E9

P356

Q34000970-84BE7876-2B58-434F-82C9-A47E2172D294

P407

Q34000970-D9C310DC-7F03-454A-A789-D29D838D7D6C

P433

Q34000970-EF9E4C33-9EDB-4DD3-B8BF-E493DC3714B2

P478

Q34000970-CE1267FC-54CC-4C30-9814-EB8C46664FBB

P577

Q34000970-43C71A05-5856-4914-A671-829E048AACDE

P5875

Q34000970-C62AD68A-D829-4B4D-AC87-204030E2BDAC

P698

Q34000970-63A7772C-B0F8-43E3-AF8D-A94DEA5EF475

P921

Q34000970-BE66CFD5-7D16-42D1-9862-453808034872

P932

Q34000970-767FA817-3715-4C6C-ACA5-B51DAECB4017

P356

P1433

Medical Physics

P1476

Variability in PET quantitation within a multicenter consortium.

@en

P2093

Frederic H Fahey

http://www.w3.org/2001/XMLSchema#string

Harold Thurston

http://www.w3.org/2001/XMLSchema#string

Mehmet Kocak

http://www.w3.org/2001/XMLSchema#string

Paul E Kinahan

http://www.w3.org/2001/XMLSchema#string

Robert K Doot

http://www.w3.org/2001/XMLSchema#string

Tina Young Poussaint

http://www.w3.org/2001/XMLSchema#string

P2860

The Neuroimaging Center of the Pediatric Brain Tumor Consortium-collaborative neuroimaging in pediatric brain tumor research: a work in progress

Standards for PET image acquisition and quantitative data analysis.

PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data, and Error.

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

ACR accreditation of nuclear medicine and PET imaging departments.

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

Partial-volume effect in PET tumor imaging.

Qualification of PET scanners for use in multicenter cancer clinical trials: the American College of Radiology Imaging Network experience.

P304

3660-3666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1118/1.3455705

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46217577

http://www.w3.org/2001/XMLSchema#string

P698

20831073

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

2905446

http://www.w3.org/2001/XMLSchema#string